Monitoring adverse drug reactions across a nationwide health care system using information technology

American Journal of Health-System Pharmacy

Volumn 69, Issue 4, 2012, Pages 321-328

  Emmendorfer, Thomas ^a   Glassman, Peter A ^b,c   Moore, Von ^c   Leadholm, Thomas C ^d   Good, Chester B ^c,e   Cunningham, Francesca ^c  

^a Veterans Affairs (VA) Pharmacy Benefits Management (PBM) Service   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c VA Center for Medication Safety   (United States)

^d VA PBM Service and Consolidated Mail Outpatient Pharmacy   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Databases; Department of Veterans Affairs; Drugs, adverse reactions; Information; Quality assurance; Records; Technology

Indexed keywords

ARTICLE; COMPUTERIZED PROVIDER ORDER ENTRY; CONCEPTUAL FRAMEWORK; DECISION SUPPORT SYSTEM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATION SYSTEM; PATIENT INFORMATION; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; VETERAN;

EID: 84857596581     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110026     Document Type: Article

References (14)

1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician'sguide to terminology, documentation, and reporting. Ann Intern Med. 2004; 140:795-801. (Pubitemid 38623529)
2. World Health Organization. Medicines: safety of medicines-adverse drug reactions, updated 2008. www.who.int/mediacentre/factsheet s / fs293/en/index.html (accessed 2010 Jun 29).
3. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
4. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003; 289:1107-16. (Pubitemid 37430324)
5. Gandhi TK, Weingart SN, Borus J et al. Adverse drug events in ambulatory care. N Engl J Med. 2003; 348:1556-64. (Pubitemid 36437933)
6. Aspinall MB, Whittle J, Aspinall SL et al. Improving adverse-drug- reaction reporting in ambulatory care clinics at a Veterans Affairs hospital. Am J Health-Syst Pharm. 2002; 59:841-5. (Pubitemid 34457201)
7. Gandhi TK, Burstin HR, Cook EF et al. Drug complications in outpatients. J Gen Intern Med. 2000; 15:149-54. (Pubitemid 30155346)
8. National Center for Veterans Analysis and Statistics, Department of Veterans Affairs. VA benefits & health care utilization (updated annually). www.va.gov/vetdata/docs/QuickFacts/4x6-fall-11-Sharepoint-Final.pdf (accessed 2012 Jan 4).
9. Veterans Health Administration, Department of Veterans Affairs. VHA Directive 2008-059: Adverse drug event reporting and monitoring. www.va.gov/vhapublications/ViewPublication.asp?pub-ID=1773 (accessed 2010 Sep 12).
10. Spina JR, Glassman PA, Belperio P et al., for the Primary Care Investigative Group of VA Greater Los Angeles. Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual. 2005; 20:7-14. (Pubitemid 40879699)
11. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45. (Pubitemid 12149145)
12. Medical Dictionary for Regulatory Activities Maintenance and Support Services Organization. Welcome to MedDRA and the MSSO. www.meddramsso.com (accessed 2011 Nov 14).
13. Department of Veterans Affairs. VistA pharmacy benefits management (PBM) extract enhancements. www4.va.gov/vdl/documents/Clinical/Pharm-Benefits-Mgmnt- (PBM)/psu-4-p3-rn.pdf (accessed 2010 Sep 12).
14. Aspinall SL, Banthin J, Good CB et al. VA pharmacy users: how they differ from other veterans. Am J Manag Care. 2009; 15:701-8.